Eli Lilly and Company       
Terra L. Fox, 317-276-5795

Eli Lilly and Company (NYSE:LLY) will be hosting a meeting with
pharmaceutical sell-side analysts on Wednesday, December 3, 2003, in
New York City. The company periodically holds these meetings with
industry analysts to review its growth strategy and pipeline. The
meeting will be webcast from 6:30 p.m. to 8:30 p.m. EST.

Sidney Taurel, chairman, president and chief executive officer for
Lilly, will attend the meeting.

Investors and the general public can access this live webcast through
a link on the investor relations section of Lilly's website at
http://investor.lilly.com/medialist.cfm. The webcast will be available
for replay through Wednesday, December 10, 2003.

Lilly, a leading innovation-driven corporation, is developing a
growing portfolio of first-in-class and best-in-class pharmaceutical
products by applying the latest research from its own worldwide
laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides
answers - through medicines and information - for some of the world's
most urgent medical needs. Additional information about Lilly is
available at www.lilly.com.